Crown Aesthetics, a division of Crown Laboratories Inc and a provider of microneedling technology, announces that the U.S. Food and Drug Administration (FDA) has cleared SkinPen Precision for the treatment of wrinkles on the neck.
The administration’s decision came following a recent single-center clinical study, which demonstrated clinical improvement of dermal lines on the neck and high patient satisfaction at 1-month and 3-months post treatment. From this study it was found that:
- 94% of patients noticed an improvement in how their wrinkles looked in their treated area one month post procedure
- 88% of patients were satisfied with their SkinPen Precision treatment one-month post procedure
The clinical trial also suggests that the SkinPen Precision device is safe for use with a depth of up to 2.5 mm on the neck. This allows patients to achieve more meaningful results with no adverse effects.
SkinPen is an FDA-cleared microneedling device now with indications for both face and neck, according to Crown Aesthetics in a media release.
“This new and expanded indication will completely change the way the industry has been treating wrinkles on the neck. SkinPen has been clinically proven to safely and effectively treat facial acne scars in patients ages 22 and up, and we are excited to now add the expanded indication to treat wrinkles on the neck.”
— Joe Proctor, President of Crown Aesthetics
[Source(s): Bellus Medical, a division of Crown Laboratories, PR Newswire]
